CryoLife (CRY) Tops Q3 EPS by 8c, Boosts FY Guidance

CryoLife (NYSE: CRY) reported Q3 EPS of $0.13, $0.08 better than the analyst estimate of $0.05. Revenue for the quarter came in at $45.3 million versus the consensus estimate of $44.9 million.

GUIDANCE:

CryoLife sees FY2016 EPS of $0.43-$0.45, versus prior guidance of $0.32-$0.34. CryoLife sees FY2016 revenue of $181-182.5 million, versus prior guidance of $180-182 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.

You May Also Be Interested In

• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance